India, May 5 -- Shares of Firefly Neuroscience, Inc. (AIFF) gains 16% on Monday morning after the company announced the acquisition of Evoke Neuroscience, Inc., a medical device company developing and commercializing technologies to aid in the comprehensive assessment of brain health.
AIFF is currently trading at $3.8210, up $0.5510 or 16.8553%, on a large volume of 22 million shares, above the average volume of 6.6 million, on the Nasdaq. The stock opened its trading at $4.2250 after closing Friday at $3.2700. The stock has traded between $1.8600 and $17.2000 in the past 52-week period.
The company said the deal marks another step toward Firefly building a proprietary foundation model of the human brain using its FDA-cleared Brain Networ...